Marit P Martinussen1, Michael B Bracken2, Elizabeth W Triche3, Geir W Jacobsen4, Kari R Risnes5. 1. Department of Obstetrics and Gynecology, St. Olav's University Hospital, Trondheim, Norway; Department of Laboratory Medicine, Children's and Women's Health, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway. Electronic address: marit.martinussen@ntnu.no. 2. Yale Center for Perinatal, Pediatric and Environmental Epidemiology, Yale University, New Haven, CT, USA. 3. Mandell Center for Multiple Sclerosis and Neuroscience Research, Mount Sinai Rehabilitation Hospital, St. Francis Care, Hartford, CT, USA. 4. Department of Public Health and General Practice, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway. 5. Department of Public Health and General Practice, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Pediatrics, St. Olav's University Hospital, Trondheim, Norway.
Abstract
OBJECTIVE: To assess whether folic acid intake during the first trimester of pregnancy is related to pregnancy outcomes preeclampsia, low birth weight or preterm birth. STUDY DESIGN: Prospective cohort study of 3647 women who were followed from the first trimester of pregnancy. Detailed information on quantity of folic acid intake before and during the first three months of pregnancy was recorded. Pregnancy outcome data were abstracted from obstetric records. RESULTS: Lean mothers who used folic acid supplementation the month before pregnancy had a 40% reduced risk of developing preeclampsia. The adjusted odds ratio (OR) with 95% confidence intervals (95%CI) for preeclampsia in lean mothers (BMI<25) who used folic acid supplements the month before pregnancy was 0.6 (95% CI 0.4-1.0). Obese mothers who used folic acid supplementation in the first trimester had an increased, but not statistically significant risk for preterm birth (adjusted OR 1.9 with 95% CI 0.9-4.0). There were no significant associations between folic acid supplementation and low birth weight. CONCLUSION: Our study supports a possible protective effect of folate intake in early pregnancy on preeclampsia in lean mothers. There was no support for any beneficial effect of folic acid use on preterm birth or low birth weight, and we found no evidence of any harmful effects of folate use for the outcomes included in our study.
OBJECTIVE: To assess whether folic acid intake during the first trimester of pregnancy is related to pregnancy outcomes preeclampsia, low birth weight or preterm birth. STUDY DESIGN: Prospective cohort study of 3647 women who were followed from the first trimester of pregnancy. Detailed information on quantity of folic acid intake before and during the first three months of pregnancy was recorded. Pregnancy outcome data were abstracted from obstetric records. RESULTS: Lean mothers who used folic acid supplementation the month before pregnancy had a 40% reduced risk of developing preeclampsia. The adjusted odds ratio (OR) with 95% confidence intervals (95%CI) for preeclampsia in lean mothers (BMI<25) who used folic acid supplements the month before pregnancy was 0.6 (95% CI 0.4-1.0). Obese mothers who used folic acid supplementation in the first trimester had an increased, but not statistically significant risk for preterm birth (adjusted OR 1.9 with 95% CI 0.9-4.0). There were no significant associations between folic acid supplementation and low birth weight. CONCLUSION: Our study supports a possible protective effect of folate intake in early pregnancy on preeclampsia in lean mothers. There was no support for any beneficial effect of folic acid use on preterm birth or low birth weight, and we found no evidence of any harmful effects of folate use for the outcomes included in our study.
Authors: S E Vollset; H Refsum; L M Irgens; B M Emblem; A Tverdal; H K Gjessing; A L Monsen; P M Ueland Journal: Am J Clin Nutr Date: 2000-04 Impact factor: 7.045
Authors: Michael B Bracken; Elizabeth W Triche; Kathleen Belanger; Karen Hellenbrand; Brian P Leaderer Journal: Am J Epidemiol Date: 2003-03-01 Impact factor: 4.897
Authors: Gary M Shaw; Suzan L Carmichael; Verne Nelson; Steve Selvin; Donna M Schaffer Journal: Public Health Rep Date: 2004 Mar-Apr Impact factor: 2.792
Authors: A L Bjørke Monsen; P M Ueland; S E Vollset; A B Guttormsen; T Markestad; E Solheim; H Refsum Journal: Pediatrics Date: 2001-09 Impact factor: 7.124
Authors: Angelika de Bree; W M Monique Verschuren; Anne-Lise Bjørke-Monsen; Nathalie M J van der Put; Sandra G Heil; Frans J M Trijbels; Henk J Blom Journal: Am J Clin Nutr Date: 2003-03 Impact factor: 7.045
Authors: Michael B Bracken; Elizabeth W Triche; Kathleen Belanger; Audrey Saftlas; William S Beckett; Brian P Leaderer Journal: Obstet Gynecol Date: 2003-10 Impact factor: 7.661
Authors: Dian Sulistyoningrum; Tim Green; Debbie Palmer; Thomas Sullivan; Simon Wood; Maria Makrides; Monika Skubisz; Karen P Best Journal: BMJ Open Date: 2020-11-16 Impact factor: 2.692